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ABSTRACT: Linkage analysis of complex traits has had limited success in identifying trait-influencing loci. Recently, coding
variants have been implicated as the basis for some biomedical associations. We tested whether coding variants are the basis
for linkage peaks of complex traits in 42 African-American (n = 596) and 90 Hispanic (n = 1,414) families in the Insulin
Resistance Atherosclerosis Family Study (IRASFS) using Illumina HumanExome Beadchips. A total of 92,157 variants
in African Americans (34%) and 81,559 (31%) in Hispanics were polymorphic and tested using two-point linkage and
association analyses with 37 cardiometabolic phenotypes. In African Americans 77 LOD scores greater than 3 were observed.
The highest LOD score was 4.91 with the APOE SNP rs7412 (MAF = 0.13) with plasma apolipoprotein B (ApoB). This
SNP was associated with ApoB (P-value = 4 × 10−19) and accounted for 16.2% of the variance in African Americans. In
Hispanic families, 104 LOD scores were greater than 3. The strongest evidence of linkage (LOD = 4.29) was with rs5882
(MAF = 0.46) in CETP with HDL. CETP variants were strongly associated with HDL (0.00049 < P-value <4.6 × 10−12),
accounting for up to 4.5% of the variance. These loci have previously been shown to have effects on the biomedical traits
evaluated here. Thus, evidence of strong linkage in this genome wide survey of primarily coding variants was uncommon.
Loci with strong evidence of linkage was characterized by large contributions to the variance, and, in these cases, are common
variants. Less compelling evidence of linkage and association was observed with additional loci that may require larger family
sets to confirm.
Genet Epidemiol 38:345–352, 2014. © 2014 Wiley Periodicals, Inc.
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Introduction
Family-based linkage analysis has been highly successful
in the study of Mendelian disorders. With few exceptions
[Hugot et al., 2001; Musunuru et al., 2010; Ogura et al.,
2001], linkage analysis has been largely unsuccessful in con-
tributing insights into the origin of complex traits or com-
mon diseases. In contrast, Genome-Wide Association Stud-
ies (GWAS) have been highly successful in identifying trait
Supporting Information is available in the online issue at wileyonlinelibrary.com.
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or disease associated common genetic variants. However, in
most cases, GWAS have identified variants of relatively small
effect sizes [Bodmer and Bonilla, 2008; Bowden, 2011] that
contribute minimally to the variance in disease or quantita-
tive traits. Investigators have speculated that low frequency
variants, especially previously untested coding variants, will
have larger effect sizes and contribute meaningfully to the
variance in complex traits and common diseases [Kiezun
et al., 2012]. Next-generation sequencing has facilitated the
generationof extensive exome-sequencing data resources and
made it possible to investigate the impact of coding variants.
In a prior exome sequencing analysis we have shown that
a low frequency (1% minor allele frequency; MAF) coding
C© 2014 WILEY PERIODICALS, INC.
Table 1. Demographic summaries of IRASFS Hispanic and African-American cohorts




Pedigree size Mean 14.2 Mean 15.7
N Mean Range SD N Mean Range SD
Age (yrs) 573 42.76 18–80 13.98 1,262 42.75 18–81 14.58
Gender 596 60.2% F 1,414 58.3% F
BMI (kg/m2) 570 29.96 15–55 6.79 1,252 28.88 16–58 6.13
ApoB (mg/dL) 565 89.74 34–191 24.48 1,152 89.08 33–201 22.69
HDL (mg/dL) 574 47.48 21–103 12.85 1,253 43.82 18–125 13.05
LDL (mg/dL) 571 114.91 31–273 34.05 1,242 109.17 31–218 30.86
Total cholesterol (mg/dL) 574 178.66 99–350 38.62 1,254 177.83 74–348 37.30
Triglycerides (mg/dL) 574 81.59 13–888 70.36 1,251 124.20 18–836 84.38
variant in the ADIPOQ gene was the basis for a linkage peak
in Hispanic families in the Insulin Resistance Atherosclerosis
Family Study (IRASFS) [Bowden et al., 2010]. Here, we have
performed an extensive analysis of family-based linkage and
combined association analysis of 37 cardiometabolic pheno-
types with data from exome chip analysis of 130Hispanic and
African-American families from the IRASFS to test the hy-
pothesis that linkage analysis of coding variants can identify
trait defining genetic variations.
Methods
Samples
The samples used in this study include both the Hispanic
and African-American cohorts from the Insulin Resistance
and Atherosclerosis Family Study (IRASFS). Ascertainment
and examination of these cohorts have been previously de-
scribed in detail [Henkin et al., 2003]. Briefly, subjects were
ascertained on the basis of large family size in San Luis Val-
ley, Colorado (Hispanics), San Antonio, Texas (Hispanics),
and Los Angeles, California (African Americans). The His-
panic cohort consisted of 1,414 individuals from 90 families,
while the African-American sample has 596 individuals from
42 families (Table 1). These subjects were extensively phe-
notyped, including a frequently sampled intravenous glu-
cose tolerance test (FSIGT), measures of blood lipids and
inflammatory markers, anthropomorphic measures, and fat
deposition measured by computed tomography (CT) scan
(Supplementary Table S1). IRB approval was obtained at all
clinical and analysis sites and all participants provided in-
formed consent.
Exome Chip Genotyping and Quality Control
Genotyping was performed at the Wake Forest Center for
Genomics and Personalized Medicine Research using the Il-
lumina HumanExome BeadChip v1.0 (596 African Ameri-
cans and 552 Hispanics) and v1.1 (862 Hispanics). Version
1.0 of the exome chip contained 247,870 variants, while
version 1.1 contained 242,901. Over 92% of the variants
were in protein coding regions. The chip also included 4761
single nucleotide polymorphisms (SNPs) previously associ-
ated with a diverse range of traits in prior GWAS (sum-
mary of exome chip design: http://genome.sph.umich.edu/
wiki/Exome_Chip_Design). Additional markers included
coverage of the HLA region, ancestry informative markers,
and SNPs for identity by descent determination. Relevant to
the study reported here, the variants on the exome chips were
chosen based on their appearance in more than one indi-
vidual and more than one cohort and thus are likely to be
observed in the general population.
Sample and autosomal SNP call rates for both the African-
American and Hispanic datasets were99%, and SNPs with
poor cluster separation (<0.35) were excluded. Mendelian
errors were identified using PedCheck [O’Connell and
Weeks, 1998] and resolved by removing conflicting geno-
types. Hardy–Weinberg Equilibrium (HWE) was assessed
for the variants on the exome chip using the program
PLINK [Purcell et al., 2007] in only the unrelated sam-
ples (N = 39 and 229, African Americans and Hispanics,
respectively), in order to reduce biases introduced by famil-
ial allele frequencies. In Hispanics, 7 variants had significant
(P < 1 × 10–5) deviation from HWE (minimum P-value =
7.2 × 10–20). African-American variants were all in accor-
dance with HWE (P > 1 × 10–5).
Individual SNP Genotyping and Quality Control
Targeted genotyping of variants in APOE (chromosome
19), the neighboring gene APOC1, and APOB (chromosome
2) was also performed, including APOE variant rs429358,
which in combination with rs7412 (contained on the ex-
ome chip) defined APOE isoforms ε2, ε3, and ε4. In ad-
dition to rs429358, SNPs were chosen from the NHLBI
ESP GO (https://esp.gs.washington.edu/drupal/) [Tennessen
et al., 2012] and 1000 Genomes [Abecasis et al., 2012]
databases to more thoroughly cover the APOE/APOC1 and
APOB regions. Coding variants seen in at least two African-
American samples from these resources were prioritized for
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genotyping, as well as variants predicted to impact splicing or
causing frame-shift changes. Genotyping of 43 SNPs was car-
ried out using the SequenomMass Array system (Sequenom;
San Diego, CA). Blind duplicates (n = 22) were genotyped
for quality control purposes and had a concordance rate of
99.6%. SNP and plate call rate thresholds were set at >90%.
PedCheck [O’Connell andWeeks, 1998] was used to identify
Mendelian inconsistencies, which were resolved by removal
of conflicting genotypes. These SNPswere combinedwith the
APOE-APOC1 and APOB variants contained on the exome
chip for further analysis.
Statistical Analysis
Marker-specific identity-by-descent (IBD) probabilities
were computed using theMonte Carlo method implemented
in SequentialOligogenic LinkageAnalysis Routines (SOLAR)
[Almasy and Blangero, 1998]. Trait variables were trans-
formed to approximate normal distributions when neces-
sary. Two-point linkage and measured genotype association
analyses were also performed using the variance components
method implemented in SOLAR, with age, gender, recruit-
ment center (in the Hispanic cohorts), ancestry proportions
(one principal component for African Americans, ADMIX-
TURE [Alexander et al., 2009] variables 2–4 for Hispan-
ics), and BMI as covariates. The measured genotype analysis,
which accounts for the nonindependence of familymembers,
involves incorporating each variant separately in amodel as a
measured covariate (the number of copies of theminor allele)
evaluating genotype-specific differences in the trait means.
The proportion of variance among the mean trait values for
the genotypes to the total phenotypic variance was estimated
as the contribution of the locus to variation in the trait.
Admixture in the Hispanic sample was estimated using an
ADMIXTURE[Alexander et al., 2009] analysis fromgenome-
wide SNP data (N = 1,034 samples) pruned for LD from
the Illumina OmniExpress as part of the Genetic and Epi-
demiologic Predictors of Glucose Homeostasis Measures in
Hispanics (GUARDIAN) Consortium [data not shown]. All
HapMap II populationswere included (CEU,YRI, CHB, JPT)
using a five population model. Admixture variables 2, 3, 4
represented variance within the IRASFS cohort while 1 and
5 did not vary within our sample. Admixture in the African-
American sample was estimated using principal components
from 39 ancestry informative markers (AIMs) and including
HapMapCEUandYRI samples for comparison [Palmer et al.,
2010]. BMI was omitted as a covariate when assessing BMI
for both association and linkage analyses, but was included
for all other measures of adiposity and body composition.
Phasing of the APOE haplotypes was carried out manually
based on the assumption that none of the individuals carried
the extremely rare ε3r isoform, in which case the SNPs are
completely predictive and phasing can be inferred.
Allelic interaction between all ApoB SNPs and the ApoE
ε2 isoform (coded 0, 1, or 2 for number of copies of the ε2
isoform)was assessed using PLINK [Purcell et al., 2007]. This
analysis was exploratory in nature and did not account for
family structure.
Results
Thegoal of this studywas to investigate the ability of family-
based linkage analysis to identify coding variants linked to
complex traits. Two-point linkage was chosen as the primary
family-based linkage analysis tool.Multipoint linkage of vari-
ants in close proximity and consequent moderate to high
linkage disequilibrium artificially inflates evidence of coseg-
regation. In the simplest scenario, a trait-defining variant
will show evidence of linkage in the simple two-point anal-
ysis approach. The combination of two-point linkage with
exome chip variants provides a comprehensive genome-wide
assessment of coding and other SNPs observed across these
American populations, i.e., are not privatemutations. Specif-
ically, we expected to observe evidence of linkage at a SNP
that directly influences the cardiometabolic trait. Given the
design of the exome chip was centered on coding variants,
this SNP would likely have an annotation reflecting the role
of the variant.
Two-point linkage analysis was performed using SOLAR
on a total of 132 families with average family size of 14.2
(African American) and 15.7 (Hispanic) (Table 1). Table 1
also summarizes sample characteristics relevant to this anal-
ysis (demographic, biometric, and lipid levels). Overall the
sample was representative of a population cross-section of
adults in these populations.
African American Two-Point Linkage
A total of 92,157 (34%) variants in African Americans,
were polymorphic and passed quality control metrics, in-
cluding Mendelian error checking. Of these, 84% (77,526)
are in coding regions, leaving 14,623 SNPs from intergenic
regions (Table 2). Assessment of HWE in this sample set
indicated that no variants deviated from the expected (P <
1.0 × 10–5). The two-point linkage analysis of the exome
chip variants with 37 cardiometabolic phenotypes (Supple-
mentary Table S1) yielded a total of nearly 3.5 million LOD
scores computed in African Americans. To summarize the
overall results (Table 2), there were a total of 19,210 LOD
scores greater than 1, 1,127 greater than 2, and 77 greater
Table 2. Descriptive summary of exome chip content broken
down by LOD score in IRASFS African Americans and Hispanics
African American Exome Chip LOD>1 LOD>2 LOD>3
N 92,157 19,210 1,127 77
Genic 77,526 14,745 832 57
Missense – 10,422 569 29
Nonsense – 61 5 0
Synonymous – 645 33 3
Hispanic Exome Chip LOD>1 LOD>2 LOD>3
N 81,559 18,840 1,216 104
Genic 66,920 14,309 891 67
Missense – 9,805 574 40
Nonsense – 83 7 0
Synonymous – 650 60 4
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Table 3. APOE locus linkage analysis and association results with ApoB levels from exome chip and follow-up single SNP
genotyping analysis in African Americans
SNP Positiona Gene Annotation MAFb LOD P-value β Variance explained
rs1081101∗ 45408076 5′ 0.10 0.00 0.31 0.18 0.001
rs405509∗ 45408838 5′ Promoter 0.29 0.67 0.0004 0.31 0.039
rs440446∗ 45409167 APOE Intron 0.22 1.53 0.20 0.13 0.010
19:45409946∗ 45409946 APOE Intron 0.013 0.044 0.045 –0.72 0.008
rs769449 45410002 APOE Synonymous 0.018 0.66 0.054 0.46 0.009
rs769451∗ 45410910 APOE Intron 0.007c 0.00 0.80 –0.092 0.000
rs11083750∗ 45411857 APOE P102R 0.025 0.00 0.57 –0.17 0.001
rs429358∗ 45411941 APOE R130C 0.21 2.54 5.4E-06 0.43 0.046
rs769455 45412040 APOE R163C 0.018 0.00 0.50 –0.25 0.001
rs121918394∗ 45412043 APOE K164Q 0.002c 0.094 0.33 –1.1 0.000
rs7412 45412079 APOE R176C 0.12 4.91 4.4E-19 –1.1 0.162
rs439401 45414451 Intergenic 0.17 1.26 0.71 0.036 0.002
rs445925 45415640 Intergenic 0.28 3.58 0.020 –0.2 0.018
rs72654452∗ 45418086 APOC1 Intron 0.009 0.43 0.0088 –1.1 0.010
rs72654456 45419555 APOC1 K56R 0.009 1.78 1.7E-06 –2.1 0.044
19:45419605∗ 45419605 APOC1 Intron 0.002c 0.00 0.59 –0.58 0.001
rs4420638 45422946 3′ 0.17 3.34 0.22 0.11 0.004
ApoE Isoform 0.099 4.44 6.6E-13 0.32 0.236
∗Indicates SNPs that were genotyped using the Sequenom platform.
a Positions determined based on hg19.
b Minor allele frequencies were computed using a subset of unrelated individuals.
c Unless indicated.
Bold indicates P-values less than 0.05 and LOD scores greater than 1. Shading indicates the two SNPs that together determine the ApoE isoform (bottom, italicized). Haplotype
frequencies for the ApoE isoform are as follows: ε2 0.099, ε3 0.677, ε4 0.224.
than 3, with a maximum identified LOD score of 4.91 with
rs7412, a SNP at the APOE locus. In addition to linkage anal-
ysis, conventional SNP association analysis was performed
accounting for family structure using SOLAR. A summary
of LOD scores greater than 3.0 is shown in Supplementary
Table S2 that lists both two-point LOD score and additive
P-value for association. With the exception of rs7412 in the
APOE locus (P-value = 4.4 × 10–19), P-values for association
in these linked variants are either nonsignificant (P > 0.05),
or, at best, suggest nominal (P > 0.0001) association.
African Americans: Apolipoprotein B Levels and APOE
The maximum LOD score in African Americans was with
the APOE SNP rs7412 (MAF = 0.12) and Apolipoprotein
B (ApoB) levels. ApoB is the primary protein component of
low-density lipoprotein particles. The rs7412 variant had a P-
value for association with ApoB of 4.4 × 10–19 (Table 3). The
estimated effect corresponds to a reduction of 22 mg/dL
in ApoB levels per minor allele of rs7412. The estimated
proportionof varianceofApoB levels as attributable to rs7412
was 16.2%. This coding variant represents an arginine to
cysteine amino acid change, which also is one of the two
components defining the much-studied ApoE isoforms. In
particular, this SNP is indicative of the ε2 isoform, which has
often been implicated as protective of cardiovascular changes,
as well as Alzheimer’s disease.
African Americans: Additional APOE, APOC1, and APOB
Genotyping
Additional APOE and APOC1 variants (absent from the
exome chip) including rs429358, the other SNP determinant
of the canonical ApoE isoforms, were also genotyped and
data analyzed as summarized in Table 3. No other genotyped
SNP showed stronger evidence of linkage or association than
rs7412, including rs429538 (MAF = 0.21). There was very
little linkage disequilibrium across the APOE region, with
only one variant having an r2 value of at least 0.40 with
one of the isoform-determining SNPs (rs7412 and rs445925;
Supplementary Fig. S1). Combining rs7412 and rs429358
into APOE haplotypes resulted in LOD = 4.40 and P-value
for association of 6.6 × 10–13 accounting for an estimated
23.6% of the variance in ApoB (Table 3). Figure 1 summa-
rizes the means of each haplogenotype for ApoE isoforms.
Haplogenotypic means were 51.4 mg/dL for homozygous ε2,
89.2 mg/dL for homozygous ε3, and 102.2 mg/dL for ho-
mozygous ε4. The figure shows the clear trend for increasing
numbers of ε2 alleles and decreasing ApoB. The statistically
significant linkage and association (LOD>3; P-value <5 ×
10–7) results for the APOE-APOC1 locus were driven largely
by the APOE haplotype based on analyses conditioning on
APOE (Supplementary Table S3). In addition, since APOE
and ApoB proteins are both components of lipoprotein par-
ticles, allelic interaction betweenAPOE ε2 isoformandAPOB
variants were assessed for their contribution to the evidence
of linkage and association. Although some APOB variants
are associated with ApoB levels, (Supplementary Table S4)
they explain little variance in ApoB levels and there was lim-
ited evidence of APOB × APOE interaction (Supplementary
Table S5),
Twopoint Linkage Analysis in Hispanic Americans
The Hispanic set resulted in 81,559 (31%) polymorphic
SNPs passing quality control (Table 2). Coding SNPs rep-
resented 82% of the polymorphic SNPs, with 14,639 ad-
ditional intergenic SNPs remaining for analysis. In this
sample set seven SNPs deviated from expected HWE
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Figure 1. Haplotypic means of ApoB levels (mg/dL) by ApoE isoform status in IRASFS African Americans. Number of samples and mean ApoB
values (also noted by the horizontal line) are indicated below each isoform type.
Equilibrium (P < 1.0 × 10–5). The linkage results for the
Hispanic sample included 18,840 LOD scores greater than
1, 1,216 greater than 2 and 104 greater than 3 (Table 2).
A previously identified linkage peak on chromosome 3 for
adiponectin [Bowden et al., 2010] was overrepresented in
the strong linkage results, which are presented in Supple-
mentary Table S6, alongside corresponding P-values for as-
sociation for those variants. Excluding the chromosome 3
locus, the most biologically interesting result was evidence of
linkage with HDL levels on chromosome 16 with a variant
in the CETP gene (rs5882, LOD = 4.29). The CETP pro-
tein is known to facilitate exchange of cholesterol esters for
triglycerides between HDL and triglyceride-rich lipoprotein
remnants.
Hispanic Americans: CETP
In addition to rs5882 there were 11 additional variants
in and near CETP on the exome beadchip. The result of
linkage and association with these variants are summarized
in Table 4. Only the initial exome chip variant, rs5882,
showed strong evidence of linkage with the next highest LOD
score being less than 2. The CETP locus has extensive evi-
dence of association with HDLwith the strongest association
(P-value = 4.6 × 10–12) seen with a promoter SNP rs247616.
Multiple other SNPs were also strongly associated, with a
range of P-values of less than 10–6. In contrast to the APOE
results, the most strongly linked SNP rs5882 was more nom-
inally associated with HDL levels (P = 0.00049). The most
significantly associated SNP in this gene region (rs247616)
accounted for 4.5% of the variance in HDL levels in this pop-
ulation while the linked SNP rs5882 explained an estimated
1.2% (Table 4).
To gain a better picture of the complex pattern of link-
age and association with HDL in the CETP locus analyses
conditioning on rs5882 (the strongest linkage) and rs247616
(the most associated) were performed (Table 5). Condition-
ing on rs5882 reduced, but did not eliminate evidence of
linkage in SNPs with prior nominal evidence of linkage (e.g.,
rs9939224) suggesting rs5882 alone does not explain the link-
age evidence. Conditional analysis of the association data,
however, suggested that rs247616 (or a SNP in high LD)
largely accounted for evidence of association with P-values
substantially reduced and only modest evidence of resid-
ual variance. It is notable that rs247616 is part of an LD
block (Supplementary Fig. S2). Although there was substan-
tial LD across the promoter region, there was less between the
coding regions of the gene (in particular, the linked SNP
rs5882) and the promoter and upstream areas of significant
association (P-value <6 × 10–7). The genotypic means of
rs247616 and rs5882 follow an additive pattern and are pre-
sented in Supplementary Table S7.
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Table 4. Analysis of exome chip results at the CETP region in Hispanics
SNP Position Gene Annotation MAFa LOD P-value β Variance explained
rs9989419 56985139 5′ 0.32 1.35 5.8E-04 –0.043 0.013
rs173539 56988044 5′ 0.27 1.78 3.4E-10 0.081 0.039
rs247616 56989590 5′ Promoter 0.27 1.71 4.6E-12 0.09 0.045
rs3764261 56993324 5′ Promoter 0.27 1.69 6.1E-12 0.09 0.044
rs1800775 56995236 5′ Promoter 0.49 0.98 1.1E-05 –0.053 0.023
rs9939224 57002732 CETP Intron 0.22 1.53 1.1E-05 –0.064 0.019
rs34716057 57003846 CETP R154W 0.0022 0.22 0.38 0.078 0.004
rs1532624 57005479 CETP Intron 0.35 1.79 1.0E-07 0.064 0.025
rs201438792 57005908 CETP S221R 0.0022 0.00 0.78 0.047 0.000
rs7499892 57006590 CETP Intron 0.19 1.18 7.0E-06 –0.068 0.018
rs5880 57015091 CETP A390P 0.077 0.07 0.0044 –0.064 0.006
rs5882 57016092 CETP V422I 0.46 4.29 4.9E-04 0.042 0.012
a MAF as computed using a subset of unrelated individuals.
Boldface text indicates P-values less than 0.05 as well as LOD scores greater than 1. Position is based on hg19.
Table 5. Conditional analyses of rs5882 and rs247616 CETP variants on HDL levels
Unconditioned Conditioning on rs5882 Conditioning on rs247616
SNP Position LOD P-value LOD P-value β Variance explained LOD P-value β Variance explained
rs9989419 56985139 1.35 5.8E-04 0.81 0.015 –0.032 0.007 0.11 0.45 –0.010 0.0015
rs173539 56988044 1.78 3.4E-10 1.11 9.2E-09 0.076 0.033 0.02 0.021 –0.144 0.0014
rs247616 56989590 1.71 4.6E-12 1.01 1.6E-10 0.085 0.039
rs3764261 56993324 1.69 6.1E-12 0.99 2.3E-10 0.085 0.038 0.00 0.91 0.012 2.5E-05
rs1800775 56995236 0.98 1.1E-05 0.55 0.0024 0.043 0.012 0.05 0.55 0.009 0.0012
rs9939224 57002732 1.53 1.1E-05 1.29 9.4E-04 –0.052 0.011 1.25 0.014 –0.037 0.006
rs34716057 57003846 0.22 0.38 0.29 0.22 0.109 0.005 0.31 0.35 0.082 0.004
rs1532624 57005479 1.79 1.0E-07 1.06 1.0E-05 0.057 0.017 0.04 0.83 0.004 1.1E-06
rs201438792 57005908 0.00 0.78 0.00 0.96 0.0085 2.5E-06 0.00 0.68 0.066 0.000
rs7499892 57006590 1.18 7.0E-06 0.98 6.1E-04 –0.056 0.010 0.79 0.0069 –0.042 0.0050
rs5880 57015091 0.07 0.0044 0.00 0.046 –0.047 0.003 0.10 0.014 –0.054 0.004
rs5882 57016092 4.29 4.9E-04 1.90 0.037 0.025 0.006
Position as determined from hg19. Boldface text indicates P-values less than 0.05 as well as LOD scores greater than 1.
Discussion
In this study, we have performed analysis of family-based
linkage and association analysis of exome chip data from 130
Hispanic-American and African-American families from the
IRASFS with 37 cardiometabolic phenotypes. The goal of the
studywas to test the hypothesis that linkage analysis of coding
variants can identify trait defining genetic variations. Based
on the exome chip design, this analysis tested primarily cod-
ing variants thatwere distributed in the general population. It
is noteworthy that it has been argued previously that linkage
is only effective when the variant or locus of interest is con-
tributing a large proportion of the variance of the disease or
trait [Risch and Merikangas, 1996; Risch, 2000]. The results
here, especially the two highlighted linkages with APOE and
CETP are consistent with this model.
APOE and CETP had the strongest evidence of linkage.
SNPs at these loci were strongly associated with the linked
traits (P-values for the top associated SNPs of 4.4 × 10–19 for
the APOE locus and 4.6 × 10–12 at the CETP locus; Tables 3
and 4). Association P-values for other SNPs on the chip with
LODs greater than 3 were more nominal (P-value >0.0001).
Given the large number of tests, we suspect that many of
the other LOD scores greater than 3 may not represent true
linkages. The twomost prominent linkage results were highly
consistent with prior genetic studies [Anuurad et al., 2009;
Chasman et al., 2008; Edmondson et al., 2011; Lu et al., 2008;
Ozturk et al., 2010] and were the focus of more detailed
analysis.
The APOE SNP rs7412 in African Americans provided the
most striking linkage and association results with the ApoB
phenotype. The association with ApoB appeared to be driven
by theAPOE locus rather than the influence of the ApoB cod-
ing locus (APOB) (Supplementary Tables S4 and S5). APOE
has been an intensively studied genetic locus from multiple
perspectives including a well-documented association with
lipid levels such as LDL cholesterol [Anand et al., 2009; Chas-
man et al., 2006, 2008, 2012; Coram et al., 2013; Klos et al.,
2008; Teslovich et al., 2010; Waterworth et al., 2010]. How-
ever, association with ApoB levels has been noted only in a
small number of studies with SNPs in the region, and the iso-
formshaveonlyhadmoderate study in this context [Chasman
et al., 2008, 2012; Ozturk et al., 2010; Surakka et al., 2012].
Particularly, Anuurad et al. showed a marked difference in
ApoB levels in African Americans, but not Caucasians by
ApoE isoform in 232 African Americans and 326 Caucasians;
P < 0.05 [Anuurad et al., 2009]. In addition to ApoB we have
assessed the linkage and association with other lipid traits
(Supplementary Table S8), and found association with LDL
(P = 7.5× 10–10), total cholesterol (P = 1.4× 10–6) andmodest
evidence of linkage and no compelling association with HDL
and triglycerides.
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In this African-American sample, the APOE isoforms ex-
plain over 23% of the variance in ApoB levels (Table 3) that
contrasts with an estimated 13% of the variance for LDL
(Supplementary Table S8). APOE was not linked to ApoB
in the larger Hispanic cohort (rs7412; LOD = 0.15) but was
associated (rs7412; P = 5.7E-06; Supplementary Table S9).
rs7412 and APOE isoforms explained a comparatively mod-
est amount of the variance of ApoB and LDL (rs7412, 3.3%
and 3.2% respectively; APOE, 2.8% and 2.8%, respectively).
Prior estimates of APOE contributions to LDL variance
range from 3.3% to 4.1% in non-African derived populations
(24–28).
The association of the CETP locus with HDL levels, seen
here in the Hispanic sample, is well documented. CETP facil-
itates exchange of cholesterol esters for triglycerides between
HDL and triglyceride-rich lipoprotein remnants. CETP has
previously been associated with HDL levels in numerous
studies, albeit with different index SNPs [Chasman et al.,
2008; Edmondson et al., 2011; Lu et al., 2008; Papp et al.,
2012; Reddy et al., 2012; Teslovich et al., 2010; Waterworth
et al., 2010; Wu et al., 2013] in which collections of vari-
ous SNPs at the CETP locus in various ethnic groups were
estimated to account for approximately 3–4% of the vari-
ance inHDL. Contribution to variance however has not been
analyzed previously in a Hispanic sample, though our pro-
portion of variance attributable to the CETP locus (5.5%)
is comparable to those seen in other ethnic groups.
Results of analysis with the CETP locus in African Ameri-
cans were qualitatively different from the Hispanics (Supple-
mentary Table S10). In African Americans, only 4 of the 15
polymorphic variants in this region were nominally associ-
ated (P-values ranging from 0.001 to 0.05). The strongest as-
sociation (P-value = 0.0010) here was with an intronic CETP
variant, rs7499892, which explained 2.3% of the HDL vari-
ance in this African-American cohort with no evidence of
linkage to HDL. This variant was monomorphic in the His-
panic sample, and was therefore not available for linkage and
association testing.
We focused here on two previously well-documented loci,
APOE andCETP, to assess performance of family-based link-
age in an exome-wide analysis. There were, however, 68 other
LOD scores greater than 1 and 11 LOD scores greater than 2
at SNPs that also have association P-values down to 1× 10–5.
These loci bear further evaluation. A number of the nomi-
nal linkages (e.g., LOD > 3) were also nominally associated
(0.0001 < P < 0.05; Supplementary Tables S2 and S4). Test-
ing of whether these more nominal linkages represent true
effects will require additional data from other family studies.
In addition, this study was based on exome chip genotyping
and therefore does not touch on the possibility that private
mutations, i.e., coding variants in a single lineage, may con-
tribute to overall variance in traits. This will be possible to
test when the planned exome sequencing of the IRASFS His-
panic families is completed. Another path of examination
in these family-based cohorts would be the examination of
single families for rare variants with high impact on a trait.
While possibly productive, the number of computed LOD
scores for 132 families with >20,000 SNPs suggests it will
be challenging to identify real linkage in a background of a
potentially very high proportion of false positives.
The results of this study emphasize the utility of ex-
ome chips and linkage analysis in detecting relevant trait-
associatedvariants. It is alsoofnote that the cohorts examined
were small (n = 600–1400) relative to extremely large GWAS.
Despite this limitation, the family-based design of these co-
horts allowed for the use of linkage analysis in conjunction
with association, which was successful in identifying high-
impact variants. TheAPOE andCETP results add to the prior
identification of a high impact variant in the ADIPOQ locus
[Bowden et al., 2010]. Thus, linkage and association were
observed in multiple scenarios: an uncommon variant (1%
MAF, ADIPOQ), a relatively common variant (12% MAF,
APOE), and a combination of common variants (CETP).
The characteristic that these have in common is a substantial
contribution to the variance in the trait. In summary, linkage
in families remains a powerful tool for discovery in human
genetics, especially when combined with conventional asso-
ciation analysis.
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